NEW YORK (GenomeWeb) – Researchers have published a new study on BiorXiv in which they combined CRISPR/Cas9 screening with single-cell transcriptome sequencing to combine the benefits of both pooled and arrayed screens.

Led by first author Paul Datlinger and senior author Christoph Bock, researchers at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences described how they combined targeted genome editing and droplet-based RNA-seq to dissect T cell signaling pathways.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A draft bill released by the US House of Representatives appropriations committee would increase the 2019 National Institutes of Health budget by 3 percent.

NBC News reports on the Earth BioGenome Project, which aims to sequence all eukaryotic life on Earth.

Bloomberg looks into privacy issues raised by law enforcement's use of genetic genealogy sites.

In Science this week: environmental DNA can help in studies of marine animals, and more.

Jun
19
Sponsored by
Advanced Cell Diagnostics

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.

Jun
20
Sponsored by
PerkinElmer

In this webinar, Michael Quail of the R&D Sequencing team at the Wellcome Trust Sanger Institute will provide an expert perspective on library prep for next-generation sequencing.

Jun
21
Sponsored by
Roche

This webinar will provide a detailed look at how a genomics lab implemented next-generation sequencing (NGS) liquid biopsy assays into its in-house clinical research program.

Jun
26
Sponsored by
Lexogen

This webinar outlines a study that sought to characterize the landscape of alternative polyadenylation (APA) in the lung cancer transcriptome in order to gain insight into the role of APA in cancer progression.